R. A. Willson

780 total citations
28 papers, 639 citations indexed

About

R. A. Willson is a scholar working on Oncology, Pharmacology and Hepatology. According to data from OpenAlex, R. A. Willson has authored 28 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Pharmacology and 9 papers in Hepatology. Recurrent topics in R. A. Willson's work include Drug Transport and Resistance Mechanisms (9 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Liver Disease Diagnosis and Treatment (4 papers). R. A. Willson is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Liver Disease Diagnosis and Treatment (4 papers). R. A. Willson collaborates with scholars based in United States, United Kingdom and Australia. R. A. Willson's co-authors include R. P. H. Thompson, Robert J. Williams, David R. Gretch, Jang H. Han, J.L. Wilson, Merlyn Sayers, Lawrence Corey, Robert L. Carithers, Michael P. Busch and Richard J. Johnson and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

R. A. Willson

25 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. A. Willson United States 11 310 258 161 84 83 28 639
C.M. Bates United Kingdom 8 280 0.9× 144 0.6× 323 2.0× 89 1.1× 34 0.4× 10 480
Arno J. Arranto Finland 13 96 0.3× 183 0.7× 231 1.4× 28 0.3× 59 0.7× 25 791
Franco Bissoli Italy 10 481 1.6× 438 1.7× 122 0.8× 26 0.3× 21 0.3× 18 661
Francis Heller Belgium 12 270 0.9× 218 0.8× 66 0.4× 36 0.4× 22 0.3× 16 671
Richard M. Green United States 7 206 0.7× 382 1.5× 155 1.0× 27 0.3× 23 0.3× 10 859
K. Martin United Kingdom 9 176 0.6× 104 0.4× 247 1.5× 58 0.7× 41 0.5× 11 412
Flavio Lirussi Italy 19 309 1.0× 770 3.0× 109 0.7× 42 0.5× 72 0.9× 61 1.4k
Giacomo Zaccherini Italy 15 435 1.4× 420 1.6× 113 0.7× 59 0.7× 32 0.4× 42 746
P C Hayes United Kingdom 22 864 2.8× 689 2.7× 142 0.9× 34 0.4× 39 0.5× 56 1.2k
Helgi K. Björnsson Iceland 8 254 0.8× 279 1.1× 625 3.9× 76 0.9× 35 0.4× 23 875

Countries citing papers authored by R. A. Willson

Since Specialization
Citations

This map shows the geographic impact of R. A. Willson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. A. Willson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. A. Willson more than expected).

Fields of papers citing papers by R. A. Willson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. A. Willson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. A. Willson. The network helps show where R. A. Willson may publish in the future.

Co-authorship network of co-authors of R. A. Willson

This figure shows the co-authorship network connecting the top 25 collaborators of R. A. Willson. A scholar is included among the top collaborators of R. A. Willson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. A. Willson. R. A. Willson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Willson, R. A., Rodney A. Hill, Jakob Magolan, et al.. (2023). <i>Garcinia buchananii</i> stem bark extract and its bioactive constituents manniflavanone, GB-2 and buchananiflavanone attenuate intestinal inhibitory neuromuscular transmission. Journal of Smooth Muscle Research. 59(0). 34–57. 1 indexed citations
3.
Brodkin, Carl A., Jai-Dong Moon, J E Camp, et al.. (2001). Serum hepatic biochemical activity in two populations of workers exposed to styrene. Occupational and Environmental Medicine. 58(2). 95–102. 28 indexed citations
4.
Willson, R. A., Susanna Fischer, & Hans D. Ochs. (1999). Long-Term Interferon Alpha Maintenance Therapy for Chronic Hepatitis C Infection in a Patient With Common Variable Immune Deficiency. Journal of Clinical Gastroenterology. 29(2). 203–206. 2 indexed citations
5.
Singh, Chanchal, et al.. (1996). Extreme hyperbilirubinemia associated with the use of anabolic steroids, health/nutritional supplements, and ethanol: response to ursodeoxycholic acid treatment.. PubMed. 91(4). 783–5. 13 indexed citations
6.
Stehman-Breen, C., et al.. (1995). Hepatitis C virus associated membranous glomerulonephritis.. PubMed. 44(3). 141–7. 91 indexed citations
7.
Gretch, David R., Lawrence Corey, J.L. Wilson, et al.. (1994). Assessment of Hepatitis C Virus RNA Levels by Quantitative Competitive RNA Polymerase Chain Reaction: High-Titer Viremia Correlates with Advanced Stage of Disease. The Journal of Infectious Diseases. 169(6). 1219–1225. 190 indexed citations
9.
Willson, R. A.. (1990). 31Phosphorus nuclear magnetic resonance spectroscopy: What does it tell us about alcohol-induced liver disease?. Hepatology. 12(5). 1246–1248. 1 indexed citations
10.
Willson, R. A., J. Hart, Tyler R. Hall, & S H Vincent. (1990). Inverse Relationship Between Total Glutathione S‐Transferase Content and Bile Acid Release in Isolated Hepatocytes from Untreated, Phenobarbital Pretreated and Hypothyroid Rats*. Pharmacology & Toxicology. 66(2). 121–127. 3 indexed citations
11.
Willson, R. A., Jacob Hart, & Tyler R. Hall. (1989). Chlorpromazine, Administered in Vivo and in Vitro, Inhibits the Efflux of Bile Acids in Freshly Isolated Rat Hepatocytes*. Pharmacology & Toxicology. 64(5). 454–458. 8 indexed citations
12.
Jiranek, Geoffrey C., Michael B. Kimmey, David Saunders, et al.. (1989). Misoprostol Reduces Gastroduodenal Injury From One Week of Aspirin: An Endoscopic Study. Gastroenterology. 96(2). 656–661. 51 indexed citations
13.
Willson, R. A., Tyler R. Hall, & J. Hart. (1988). Oxmetidine (H2 receptor antagonist) induced cytotoxicity in isolated rat hepatocytes. Journal of Applied Toxicology. 8(3). 223–225. 5 indexed citations
15.
Willson, R. A., et al.. (1981). The comparison of in vivo plasma radioactivity clearance and 14CO2 breath elimination of model drugs in the rat: A study in regional hepatocyte function. Toxicology and Applied Pharmacology. 61(2). 177–184. 6 indexed citations
16.
Willson, R. A.. (1981). Chronic refractory encephalopathy. Digestive Diseases and Sciences. 26(9). 839–842. 4 indexed citations
17.
Willson, R. A., et al.. (1978). In vitro and in vivo aminopyrine metabolism in ethinyl estradiol (EE) induced cholestasis in the rat. Gastroenterology. 75(5). 994–994.
18.
Gazzard, B G, R. A. Willson, M.J. Weston, R. P. H. Thompson, & Robert J. Williams. (1974). CHARCOAL HAEMOPERFUSION FOR PARACETAMOL OVERDOSE. British Journal of Clinical Pharmacology. 1(3). 271–275. 32 indexed citations
19.
Willson, R. A., et al.. (1973). Reduction of Absorption of Paracetamol by Activated Charcoal and Cholestyramine: A Possible Therapeutic Measure. BMJ. 3(5871). 86–87. 96 indexed citations
20.
Clark, Russ, et al.. (1972). The British Society of Gastroenterology. Gut. 13(10). 836–857. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026